Total Payments
$9,379
2024 Payments
$3,615
Companies
24
Transactions
313
Medicare Patients
270
Medicare Billing
$30,851
Payment Breakdown by Category
Food & Beverage$9,274 (98.9%)
Education$105.26 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,274 | 311 | 98.9% |
| Education | $105.26 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,333 | 74 | $0 (2024) |
| Janssen Biotech, Inc. | $1,005 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $993.81 | 51 | $0 (2024) |
| Gilead Sciences, Inc. | $767.65 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $603.39 | 28 | $0 (2024) |
| QOL Medical, LLC | $552.18 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $367.51 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $365.35 | 3 | $0 (2022) |
| Lilly USA, LLC | $328.23 | 9 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $314.46 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,615 | 134 | Gilead Sciences, Inc. ($582.83) |
| 2023 | $3,673 | 122 | ABBVIE INC. ($1,174) |
| 2022 | $2,091 | 57 | ABBVIE INC. ($614.09) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $95.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.06 | General |
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.95 | General |
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.88 | General |
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: GI | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: Immunology | ||||||
| 11/05/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: GI | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Immunology | ||||||
| 10/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $52.71 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 121 | 135 | $36,147 | $10,642 |
| 2022 | 2 | 31 | 31 | $4,657 | $1,728 |
| 2021 | 3 | 118 | 288 | $39,690 | $18,481 |
Total Patients
270
Total Services
454
Medicare Billing
$30,851
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 45 | $10,080 | $3,417 | 33.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 23 | $9,637 | $2,726 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $9,889 | $2,661 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 27 | $4,077 | $1,321 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,464 | $516.73 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 19 | $2,869 | $1,143 | 39.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 12 | $1,788 | $585.12 | 32.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 45 | 170 | $25,500 | $10,838 | 42.5% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 36 | 42 | $7,350 | $3,969 | 54.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 37 | 76 | $6,840 | $3,675 | 53.7% |
About Dale Sumilang
Dale Sumilang is a Registered Nurse healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2020. The National Provider Identifier (NPI) number assigned to this provider is 1154938744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dale Sumilang has received a total of $9,379 in payments from pharmaceutical and medical device companies, with $3,615 received in 2024. These payments were reported across 313 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($9,274).
As a Medicare-enrolled provider, Sumilang has provided services to 270 Medicare beneficiaries, totaling 454 services with total Medicare billing of $30,851. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Acute Care
- Location Providence, RI
- Active Since 09/28/2020
- Last Updated 12/04/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1154938744
Products in Payments
- SKYRIZI (Biological) $1,169
- STELARA (Biological) $1,004
- RINVOQ (Biological) $955.88
- XIFAXAN (Drug) $830.96
- ENTYVIO (Biological) $434.55
- ZEPOSIA (Drug) $347.05
- TREMFYA (Drug) $317.87
- Linzess (Drug) $314.46
- OMVOH (Drug) $303.63
- SUCRAID (Drug) $291.51
- EXALT Model D (Device) $263.99
- ZENPEP (Drug) $261.47
- Sucraid (Drug) $260.67
- VOQUEZNA (Drug) $247.98
- REBYOTA (Biological) $213.01
- GATTEX (Drug) $168.84
- TRULANCE (Drug) $162.85
- Talicia (Drug) $154.46
- LINZESS (Drug) $127.11
- Epclusa (Drug) $121.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Providence
Nicole Allison, Cns, CNS
Registered Nurse — Payments: $11,944
Registered Nurse $11,944
Shandrea Rodriguez, Fnp, FNP
Registered Nurse — Payments: $7,695
Registered Nurse $7,695
Akos Antwi, Aprn, Pmhnp, APRN, PMHNP
Registered Nurse — Payments: $6,065
Registered Nurse $6,065
Sandra Ferraz
Registered Nurse — Payments: $5,793
Registered Nurse $5,793
Donna Mcdonald, Aprn, APRN
Registered Nurse — Payments: $3,657
Registered Nurse $3,657
Ms. Nicole Flanagan, Pmhnp-Bc, Msn, Rn,Ba, PMHNP-BC, MSN, RN,BA
Registered Nurse — Payments: $3,611
Registered Nurse $3,611